57 studies were found. Here are studies 1 to 50.

1.		No longer recruiting	3 Different Dose Levels of CCI-779 in Subjects with Active Rheumatoid Arthritis on Concomitant Methotrexate Therapy Condition: Rheumatoid Arthritis
2.		Recruiting	Active Crohn’s Disease Study Condition: Crohn Disease
3.		Recruiting	Acute Myeloid Leukemia Study Condition: Acute Myeloid Leukemia
4.		Completed	Acute Myeloid Leukemia Study Condition: Acute Myeloid Leukemia
5.		No longer recruiting	Adult Outpatients with Major Depressive Disorder Condition: Major Depressive Disorder
6.		Recruiting	Advanced Renal Cell Carcinoma Conditions: Carcinoma, Renal Cell; Kidney Neoplasms
7.		No longer recruiting	Breast Neoplasms Study Condition: Breast Neoplasms
8.		No longer recruiting	CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse Condition: recurrent adult acute myeloid leukemia
9.		No longer recruiting	CMA-676 in Treating Patients With Acute Myeloid Leukemia in First Relapse Condition: recurrent adult acute myeloid leukemia
10.		No longer recruiting	Colorectal Cancer Condition: Colorectal Neoplasms
11.		Recruiting	Comparison Study of Tigecycline to Imipenem/Cilastatin to Treat Complicated Intra-Abdominal Infections in Hospitalized Subjects Conditions: Surgical Wound Infection; Abdominal Abscess
12.		No longer recruiting	Diabetic Foot Infection Study Condition: Ulcer, Diabetic Foot
13.		Recruiting	Dose-finding, open-label study in patients with Acute Myelogenous Leukemia after they receive a transplantation Condition: Acute Myelogenous Leukemia
14.		Recruiting	DVS-233 SR For Prevention Of Depressive Relapse In Adult Outpatients With Major Depressive Disorder Condition: Major Depressive Disorder
15.		No longer recruiting	Efficacy And Safety Of Three Fixed Doses Of DVS-233 SR In Adult Outpatients With Major Depressive Disorder Condition: Major Depressive Disorder
16.		Recruiting	Efficacy and Safety of TMI-005 in Subjects with Active Rheumatoid Arthritis on a Background of Methotrexate Condition: Rheumatoid Arthritis
17.		No longer recruiting	Efficacy And Safety Of Two Fixed Doses Of DVS-233 SR In Adult Outpatients With Major Depressive Disorder Condition: Major Depressive Disorder
18.		No longer recruiting	End- Stage Renal Disease – High Risk Transplant Recipients Condition: End-Stage Renal Disease
19.		No longer recruiting	Evaluation of Recombinant Human Factor IX (BeneFIX) and a New Formulation of BeneFIX (rFIX-R) in Previously Treated Patients with Moderate to Severe Hemophilia B Condition: Hemophilia B
20.		Not yet recruiting	Hematologic Neoplasms Study Condition: Hematologic Neoplasms
21.		Completed	Hemophilia A Study Condition: Hemophilia A
22.		No longer recruiting	Hemophilia A Study Condition: Hemophilia A
23.		No longer recruiting	Idiopathic Pulmonary Fibrosis Condition: Pulmonary Fibrosis
24.		Recruiting	Intra-abdominal Infection Study Conditions: Abscess, Intra-Abdominal; Peritonitis
25.		Recruiting	Intravenous Tigecycline Versus Intravenous Levofloxacin To Treat Subjects Hospitalized With Community-Acquired Pneumonia Condition: Pneumonia
26.		Recruiting	Left-Sided Ulcerative Colitis Study Condition: Ulcerative Colitis
27.		No longer recruiting	Long-term administration of sirolimus (rapamune™) in solid organ transplant recipients study Condition: Organ Transplantation
28.		Recruiting	MST-997 in Subjects with Advanced Malignant Solid Tumors Conditions: Breast Cancer; Neoplasms, Breast; Non-Small-Cell Lung Carcinoma
29.		No longer recruiting	Multiphase Efficacy Study of venlafaxine ER to Treat Recurrent Depression Condition: Depression
30.		Recruiting	Non-small cell lung cancer refractory to platinum-based therapy Condition: Carcinoma, Non-Small-Cell Lung
31.		Completed	An Open Parallel Study to Determine the Optimum Dosing Schedule for AS-101 in AIDS/ARC Patients Condition: HIV Infections
32.		Recruiting	Oral CCI-779 Administered in Combination with Letrozole vs. Letrozole Alone in Postmenopausal Women with Locally Advanced or Metastatic Breast Cancer Conditions: Breast Cancer; Metastases
33.		No longer recruiting	Panic Disorder Study Condition: Panic Disorder
34.		No longer recruiting	Panic Disorder Study Condition: Panic Disorder
35.		Recruiting	Peptic Ulcer Hemorrhage Study Condition: Peptic Ulcer Hemorrhage
36.		Recruiting	Peptic Ulcer Hemorrhage Study Condition: Peptic Ulcer Hemorrhage
37.		Recruiting	A Phase 1 Study of CMC-544 Administered as a Single Agent in Subjects With B-Cell Non-Hodgkin’s Lymphoma Conditions: Lymphoma, Non-Hodgkin's; B-Cell Lymphoma
38.		No longer recruiting	A Phase 2 Study of Single Agent EKB-569 in Subjects with Advanced Colorectal Cancer. Condition: Colorectal Cancer
39.		Terminated	Randomized Safety, Tolerability and Pilot Efficacy of AN-1792 in Alzheimer's Disease Condition: Alzheimer's Disease
40.		Recruiting	A Randomized, Open-Label, Comparative Evaluation Of Conversion From Calcineurin Inhibitor Treatment To Sirolimus (Rapamune) Treatment versus Continued Calcineurin Inhibitor Treatment In Liver Allograft Recipients Undergoing Maintenance Therapy Conditions: Liver Transplantation; Hepatic Transplantation
41.		Recruiting	Recombinant Human Factor IX (rFIX; BeneFIX®) in Previously Treated Patients (PTPs) with Hemophilia B Condition: Hemophilia B
42.		Recruiting	ReFacto® in Subjects with Hemophilia A Undergoing Major Surgery Condition: Hemophilia A
43.		No longer recruiting	Renal Allograft Recipients Study Condition: Renal Allograft Recipients
44.		Completed	A Safety, Pilot Pharmacokinetics and Neurocognitive Study of AS-101 in Combination With Zidovudine in AIDS/ARC Patients Condition: HIV Infections
45.		No longer recruiting	Severe Hemophilia A Study Condition: Hemophilia A
46.		Recruiting	Severe Hemophilia B Study Condition: Hemophilia B
47.		Terminated	Study of 3 Fixed Doses of EAA-090 in Adult Outpatients with Neuropathic Pain Associated with Diabetic Neuropathy Condition: Diabetic Neuropathy, Painful
48.		Recruiting	Study of a Flexible Dose of DVS-233 SR in Adult Outpatients with Major Depressive Disorder Conditions: Depression; Depressive Disorder; Major Depressive Disorder
49.		Recruiting	Study Of DVS-233 SR And Venlafaxine ER In Adult Outpatients With Major Depressive Disorder Condition: Major Depressive Disorder
50.		Recruiting	Study of DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive Disorder Condition: Major Depressive Disorder